Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers find role RNA plays in progress of Alzheimer’s disease

11.11.2003


Researchers at Ohio State University have found new clues to how free radicals can contribute to the development of Alzheimer’s disease.


C. Glenn Lin



The study found that oxidation – a type of damage to cells caused by free radicals – can damage certain kinds of messenger RNA in the brain. That damage may be related to Alzheimer’s.

Messenger RNA (or mRNA) is important because it turns DNA’s genetic code into the proteins needed for healthy brain function. But in an Alzheimer’s brain, up to half of the mRNA are damaged by oxidation; these oxidized mRNAs may process proteins abnormally, which may contribute to neuronal death.


“We know that free radicals can damage DNA, but nobody had looked at the effect of free radicals on RNA," said C. Glenn Lin, the study’s lead author and an assistant professor of neuroscience at Ohio State. "When we looked for mRNA in the Alzheimer’s brain, we found significant amounts of oxidized mRNA in the frontal cortex, which is one of the main areas affected by the disease."

The researchers looked at the brains of deceased Alzheimer’s patients and found that only certain kinds of mRNA are susceptible to oxidative damage. There are many, some of which researchers have yet to discover, Lin said.

This is the first study to describe the specific types, or species, of mRNA oxidized in Alzheimer’s disease; until this point, researchers knew that the oxidation of mRNA played a role in Alzheimer’s disease, but they didn’t know which species were at fault.

Lin and Ohio State colleagues Xiu Shan and Hirofumi Tashiro, both with the department of neuroscience, reported their findings on November 10 in New Orleans at the annual Society for Neuroscience conference.

The researchers used tissue taken from the brains of 11 recently deceased Alzheimer’s patients (aged 65 to 86); seven age-matched controls; and two young control subjects (aged 22 and 49). Using a series of biochemical testing methods, they analyzed mRNA content from the hippocampus, frontal cortex and cerebellum of each person’s brain. They were looking for mRNA transcripts – replicas of DNA genetic code – to see if certain transcripts were more susceptible to oxidation.

The researchers also wanted to see if they would find the same level of mRNA oxidation in the brains of the age-matched and young controls to determine whether or not this level of mRNA oxidation was truly unique to Alzheimer’s disease.

Alzheimer’s disease first attacks the hippocampus, virtually destroying its ability to help regulate memory. Damage to the frontal cortex – an area important for cognition – follows. The cerebellum is usually unaffected in Alzheimer’s, Lin said.

The researchers found high levels of oxidative damage in the frontal cortex of only the Alzheimer’s patients’ brains. They also found that only certain mRNA species were oxidized.

"We were somewhat surprised to find that free radical damage wasn’t a random hit in the brain," Lin said. "But many of the oxidized mRNA species were related to genes already known to be associated with Alzheimer’s disease."

This oxidation appears to start early in the disease process, Lin said, and the disease progressively worsens as proteins continue to accumulate.

"Protein aggregation is one of the hallmark features of Alzheimer’s disease," Lin said. "We think that mRNA oxidation and subsequent protein accumulation may strongly interfere with the brain’s normal cellular processes, which may contribute to the onset and progression of Alzheimer’s."

Lin said he hopes that some day researchers will be able to pinpoint the exact kinds of mRNA transcripts that cause protein aggregation.
"That might help us figure out what kind of proteins in the cell go haywire at an early stage of Alzheimer’s," he said. "Then, if we can somehow block that process, perhaps we could reduce the progression of the disease."

The research was supported by grants from the National Institutes of Health and the Alzheimer’s Association.


Contact: C. Glenn Lin; (614) 688-5433; Lin.492@osu.edu
Written by Holly Wagner, (614) 292-8310; Wagner.235@osu.edu

Holly Wagner | OSU
Further information:
http://researchnews.osu.edu/archive/sfnad.htm

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Single nanoparticle mapping paves the way for better nanotechnology

24.10.2017 | Physics and Astronomy

A quantum spin liquid

24.10.2017 | Physics and Astronomy

Antibiotic resistance: a strain of multidrug-resistant Escherichia coli is on the rise

24.10.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>